Boston Partners Trans Medics Group, Inc. Transaction History

Boston Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$20.56 - $32.15 $190,344 - $297,644	-9,258 Reduced 49.22%	9,553 $300,000
Q1 2022 May 10, 2022	BUY	$12.58 - $26.94 $28,317 - $60,641	2,251 Added 13.59%	18,811 $507,000
Q4 2021 Feb 04, 2022	BUY	$19.16 - $32.68 $317,289 - $541,180	16,560 New	16,560 $317,000
Q1 2020 May 13, 2020	SELL	$10.5 - $20.2 $112,087 - $215,635	-10,675 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$16.61 - $21.64 $109,991 - $143,300	6,622 Added 163.39%	10,675 $203,000
Q3 2019 Nov 20, 2019	BUY	$20.27 - $28.93 $82,154 - $117,253	4,053 New	4,053 $96,000

391

31.3M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.13B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.